article · Journal of Drug Delivery and Therapeutics
This study compared the neuroprotective potentials of kolaviron and ethanolic leaf extract of Bryophyllum pinnatum on apopotic biomarkers (ERK, TNF-α and BDNF) in AlCl₃-induced neurotoxicity. Forty-two male Wistar rats (n = 6 per group) were allocated to seven groups: Normal control; AlCl₃ only (100 mg/kg AlCl₃); Kolaviron only (Kv, 200 mg/kg); Crassulaceae only (Cr, 600 mg/kg); AlCl₃ + Kv; AlCl₃ + Cr; and AlCl₃ + Kv + Cr. Treatments were administered orally for 28 days. Results shows that ERK (%) was 100.0 ± 4.3 (Control), 320.1 ± 2.1 (AlCl₃), 90.2 ± 4.5 (Kv), 95.7 ± 5.1 (Cr), 150.2 ± 10.3 (AlCl₃+Kv), 185.7 ± 9.8 (AlCl₃+Cr) and 172.4 ± 8.7 (AlCl₃+Kv+Cr). Serum TNF‑α (pg/mL) was 22.00 ± 11.43 (Control), 254.0 ± 5.41 (AlCl₃), 26.00 ± 10.68 (Kv), 22.05 ± 11.92 (Cr), 112.90 ± 2.02 (AlCl₃+Kv), 180.20 ± 48.96 (AlCl₃+Cr) and 27.35 ± 4.19 (AlCl₃+Kv+Cr). The results of BDNF (ng/mL) in control group was 2.50 ± 0.30 and 1.5 ± 0.20 in AlCl₃ group. The results showed significant (p<0.05) increased in ERK and TNF-α in AlCl₃ group with a corresponding deceased in BDNF in AlCl₃ group when compared with control. But, interventions with Kolaviron and Crassulaceae decreased ERK and TNF-α with a concurrent increased in BDNF level. Kolaviron more strongly suppressed TNF-α and ERK hyperactivation, whereas Crassulaceae more effectively restored BDNF. The combined treatment produced more amelioration, substantially lowering ERK and TNF-α and improving BDNF toward control levels, attenuating the damaging effect of AlCl₃ on the brain cells. Keywords: Neurodegeneration, Kolaviron; Bryophyllum pinnatum; Aluminium chloride; ERK; TNF-α; BDNF.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.22270/jddt.v16i3.7613
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.